Ivan Dimov
About Ivan Dimov
Ivan Dimov is the co-founder and CEO of Orca Bio, a company launched in 2016, and a former CTO of Lucira Health, with a strong background in biophysics and microfluidic technology.
Ivan Dimov, Co-founder and CEO of Orca Bio
Ivan Dimov is the Co-founder and Chief Executive Officer of Orca Bio, a biotechnology company launched in 2016. Under his leadership, Orca Bio has focused on innovative treatments and solutions within the biotech industry. Before founding Orca Bio, Dimov served as the Chief Technology Officer at Lucira Health, where he contributed to the development of advanced health technologies.
Ivan Dimov's Education and Academic Background
Ivan Dimov holds a PhD in applied biophysics from Dublin City University. He also earned bachelor's and master's degrees in electronics, telecommunications, and computer science from Universidad Técnica Federico Santa María in Chile. He has a rich academic background, including roles as a senior scientist and visiting instructor in Irv Weissman's laboratory at Stanford University, as well as a visiting research scholar at the BioPOETS Lab at the University of California, Berkeley.
Research and Innovation by Ivan Dimov
Ivan Dimov has developed innovative microfluidic platforms for stem cell research and low-cost molecular diagnostics. His work in this area has led to significant advancements in biotechnology and medical research. Additionally, he founded BlobCode Technologies, further showcasing his dedication to innovation and cutting-edge technology.
Ivan Dimov's Contributions to Robotics and Hospital Technologies
Ivan Dimov established two research centers in Chile, focusing on robotics and hospital technologies. These centers have been instrumental in advancing research and development in their respective fields, showcasing Dimov's commitment to leveraging technology to improve patient care and medical practices.
Publications and Patents by Ivan Dimov
Ivan Dimov has an impressive academic portfolio, with more than 40 articles published in peer-reviewed journals. His contributions to the scientific community are further exemplified by his collection of over 40 patents or patent applications, demonstrating his active role in research and development.